Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaSattva S. Neelapu, William Y. Go, David B. Miklos et al.|New England Journal of Medicine|2017Cited by 6k
Kte-C19 (anti-CD19 CAR T Cells) Induces Complete Remissions in Patients with Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Results from the Pivotal Phase 2 Zuma-1Sattva S. Neelapu, William Y. Go, Frederick L. Locke et al.|Blood|2016Cited by 51